Principal Investigators

    LEHMANN Sylvain

    Institution

    CHU Montpellier

    Contact information of lead PI

    Country

    France

    Title of project or programme

    Utilisation de la protéomique quantitative ciblée et du marquage aux isotopes stables pour le diagnostic et l’étude des affections neurologiques et en particulier de la maladie d’Alzheimer. Use of targeted quantitative proteomics and stable isotope labeling for the diagnosis and study of neurological disorders and in particular of Alzheimer's disease.

    Source of funding information

    DGOS

    Total sum awarded (Euro)

    € 966,000

    Start date of award

    xx/xx/2010

    Total duration of award in years

    6.0

    The project/programme is most relevant to:

    Alzheimer's disease & other dementias

    Keywords

    Research Abstract

    Lay Summary

    Further information available at:

Types: Investments > €500k
Member States: France
Diseases: Alzheimer's disease & other dementias
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF